Clinical trials
Recruiting Cognitive Dysfunction trials in Germany
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
16 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2021 | 2 |
| 2022 | 2 |
| 2023 | 1 |
| 2024 | 2 |
| 2025 | 7 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 16 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Bristol-Myers Squibb | 2 |
| Ludwig-Maximilians - University of Munich | 2 |
| University Medicine Greifswald | 2 |
| Henrik Bo Wiberg Larsson | 1 |
| Max Planck Institute for Human Cognitive and Brain Sciences | 1 |
| Max-Planck-Institute of Psychiatry | 1 |
| RWTH Aachen University | 1 |
| Region Skane | 1 |
| Société des Produits Nestlé (SPN) | 1 |
| University Hospital, Bonn | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Cognitive Dysfunction | 16 |
| Alzheimer Disease | 6 |
| Dementia | 6 |
| Amyloid Neuropathies, Familial | 1 |
| Basal Ganglia Diseases | 1 |
| Brain Diseases | 1 |
| Breast Neoplasms | 1 |
| Central Nervous System Diseases | 1 |
| Delirium | 1 |
| Diabetes Mellitus | 1 |
Trials
Showing 1 to 16 of 16. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.